Last Price
294.53
Today's Change
-8.50 (2.80%)
Day's Change
293.50 - 302.45
Trading Volume
307,304
Overview
Market Cap
142 Billion
Shares Outstanding
484 Million
Avg Volume
636,494
Avg Price (50 Days)
298.77
Avg Price (200 Days)
291.21
PE Ratio
36.26
EPS
8.12
Earnings Announcement
12-Feb-2025
Previous Close
303.03
Open
301.00
Day's Range
293.5 - 302.45
Year Range
228.65 - 313.55
Trading Volume
307,807
Price Change Highlight
1 Day Change
-2.82%
5 Day Change
-2.14%
1 Month Change
0.28%
3 Month Change
-5.53%
6 Month Change
9.27%
Ytd Change
2.14%
1 Year Change
24.35%
3 Year Change
-0.06%
5 Year Change
18.06%
10 Year Change
296.06%
Max Change
35521.23%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
Qantas Faces Hefty Payout to Workers Illegally Fired in Pandemic
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
